VANCOUVER, BC /TheNewswire /May 27, 2022 /AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) ("AREV" or the "Company") is pleased to announce the issuance of the retention warrant offering as announced April 8, 2022.

AREV is pleased to announce a retention warrant offering to its senior management of Mike Withrow, CEO, and Kevin Phelps, COO. Each of the retention warrants are being sold to the purchase price of $0.05 per retention share purchase warrant and exercisable at $0.23 per common share during a term of 4 years from the date of closing of the retention warrant offering. The exercise of such warrant shall be subject to...